228 related articles for article (PubMed ID: 30608910)
1. Cutaneous Involvement in a High Grade B-Cell Lymphoma With Rearrangement of MYC, BCL2, and BCL6 Transformed From Follicular Lymphoma.
Martinez-Mera C; Herrero-Moyano M; López-Elzaurdia C; Loscertales J; Aragües M
Am J Dermatopathol; 2019 Jan; 41(1):80-82. PubMed ID: 30608910
[No Abstract] [Full Text] [Related]
2. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
[TBL] [Abstract][Full Text] [Related]
3. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
Behdad A; Boddy CS; Fought AJ; Taxter T; Falkiewicz MK; Ayers E; Chen QC; Chen YH; Karmali R; Pro B; Winter JN; Landsburg DJ; Gordon LI; Kaplan JB
Leuk Lymphoma; 2019 Dec; 60(13):3266-3271. PubMed ID: 31225766
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
[TBL] [Abstract][Full Text] [Related]
7. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
[TBL] [Abstract][Full Text] [Related]
8. High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.
Moore AM; Moshkin O; Swain GJ; Crocker S; LeBrun DP
Diagn Pathol; 2018 May; 13(1):34. PubMed ID: 29793519
[TBL] [Abstract][Full Text] [Related]
9. Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Stengel A; Kern W; Meggendorfer M; Haferlach T; Haferlach C
Br J Haematol; 2019 Jun; 185(5):951-954. PubMed ID: 30460680
[No Abstract] [Full Text] [Related]
10. Deletion of C-MYC in the spectrum of transformed follicular lymphoma grade 3b.
Tzankov A; Höllrigl A; Verdorfer I; Oxle H
Hum Pathol; 2007 Jan; 38(1):191-2; author reply 192-3. PubMed ID: 17169631
[No Abstract] [Full Text] [Related]
11. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.
Ikoma H; Miyaoka M; Hiraiwa S; Yukie Kikuti Y; Shiraiwa S; Hara R; Kojima M; Ohmachi K; Ando K; Carreras J; Nakamura N
Pathol Int; 2022 Jun; 72(6):321-331. PubMed ID: 35297566
[TBL] [Abstract][Full Text] [Related]
13. Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?
Katsushima H; Fukuhara N; Konosu-Fukaya S; Himuro M; Kitawaki Y; Ichikawa S; Ishizawa K; Sasano H; Harigae H; Ichinohasama R
Leuk Lymphoma; 2018 Mar; 59(3):758-762. PubMed ID: 28771060
[No Abstract] [Full Text] [Related]
14. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous involvement of high-grade B-cell lymphoma with MYC and BCL6 rearrangements: A case report.
Maejima E; Oishi N; Ogawa Y; Okamoto T; Mitsui H; Shimada S; Kawamura T
J Dermatol; 2023 Aug; 50(8):e243-e244. PubMed ID: 36890662
[No Abstract] [Full Text] [Related]
16. Mutational landscape of high-grade B-cell lymphoma with
Künstner A; Witte HM; Riedl J; Bernard V; Stölting S; Merz H; Olschewski V; Peter W; Ketzer J; Busch Y; Trojok P; Bubnoff NV; Busch H; Feller AC; Gebauer N
Haematologica; 2022 Aug; 107(8):1850-1863. PubMed ID: 34788985
[TBL] [Abstract][Full Text] [Related]
17. What does MYC, BCL2, and BCL6 genes 'rearranged' mean in large cell/diffuse B-cell lymphomas?
Trombetta D; Zanelli M; Garuti A; Carosi I; Mastracci L; Ascani S; Graziano P; Parente P
Pathol Res Pract; 2022 Dec; 240():154199. PubMed ID: 36368276
[No Abstract] [Full Text] [Related]
18. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
20. EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements.
Nam MH; Hsieh YY; Chen BJ
Pathology; 2022 Aug; 54(5):634-636. PubMed ID: 34872752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
